Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1611 1614 1616 1617
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18023594 | COMPOSITIONS AND METHODS FOR TREATING AMYLOID-RELATED CONDITIONS | Final Rejection | The Regents of the University of California |
| 17773974 | CARDIOPROTECTIVE MICROBUBBLE-LIPOSOMAL DRUG COMPLEXES | Final Rejection | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 17927575 | COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID LEUKEMIAS TO CHEMOTHERAPY | Final Rejection | Duke University |
| 18000923 | NOVEL FORMULATIONS FOR INCREASING THE GERMINATION RATE OF FUNGAL SPORES | Final Rejection | DANSTAR FERMENT AG |
| 18013174 | THERAPEUTIC AGENT FOR DRUG-INDUCED BRADYCARDIA AND BRADYARRHYTHMIA | Non-Final OA | NISSAN CHEMICAL CORPORATION |
| 18037712 | SAFFRON AS ANTI-INFLAMMATORY AGENT IN TREATING INFLAMMATORY BOWEL DISEASE | Final Rejection | HOWARD UNIVERSITY |
| 18245055 | USE OF ESTER GROUP-CONTAINING AROMATIC PROPIONAMIDE COMPOUND IN PREPARATION OF MEDICINE FOR TREATING DRY EYE SYNDROME | Final Rejection | CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy